Federal grant · cooperative agreement (b)
Development of Machine Learning Software to Quantitatively Map Telomere Induced Senescence in Tissue Sections During Aging - Project Summary/abstract Cellular Senescence Is a Pillar of Aging, Acting as a Key Driver of Aging and Age-related Diseases. Telomeres Play a Major Role in Cellular Senescence. When Telomeres Become Critically Short or Damaged, They Elicit a Dna Damage Response (DDR) That Drives Senescence. Our Laboratory Developed Sophisticated Methods to Detect Senescent Cells in Tissues Based on the Co-localization Between Telomeres and the DDR. Furthermore, We Recently Developed Senoquant, a Software That Simplifies the Measure of Telomere Associated Foci (taf), Reducing Quantification Time From Weeks to Hours. We Now Propose to Apply Emerging Technologies Such as Machine Learning and Deep Learning to Map Taf More Accurately and Robustly in Human Tissue Sections. This Will Address Several Challenges Inherent to Taf Analysis, Including Nuclei Detection, Staining Artifacts, and Quantification Time. Furthermore, in Collaboration With the Tissue Mapping Centers We Will Tailor Senoquant to the Analysis of Specific Human Tissues. Finally, We Propose to Integrate Taf With Multiplexed Imaging Methods Such as Imaging Mass Cytometry (imc), Allowing the Detection of Multiple Senescence Markers in Tissues Simultaneously. We Anticipate That This Technology Will Greatly Advance the Spatially-resolved Mapping of Senescent Cells in Human Tissues and Will Be a Great Resource for the Aging and Cell Senescence Community.
Committed
$1.6 Million
Paid out
$1.2M
75%
Committed, not yet paid
$410.9K
25%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…